Patents by Inventor Mark Maffitt

Mark Maffitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OLIGONUCLEOTIDE REPLACEMENT FOR DI-TAGGED AND DIRECTIONAL LIBRARIES
    Publication number: 20210261951
    Abstract: Transposomes and oligonucleotide replacement methods to make DNA libraries that have distinct 5? and 3? tags, and to make directional libraries that are enriched for a desired strand.
    Type: Application
    Filed: April 29, 2021
    Publication date: August 26, 2021
    Inventors: Igor Goryshin, Bradley Baas, Ramesh Vaidyanathan, Mark Maffitt
  • Oligonucleotide replacement for di-tagged and directional libraries
    Patent number: 11008567
    Abstract: Transposomes and oligonucleotide replacement methods to make DNA libraries that have distinct 5? and 3? tags, and to make directional libraries that are enriched for a desired strand.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: May 18, 2021
    Assignee: Illumina, Inc.
    Inventors: Igor Goryshin, Bradley Baas, Ramesh Vaidyanathan, Mark Maffitt
  • OLIGONUCLEOTIDE REPLACEMENT FOR DI-TAGGED AND DIRECTIONAL LIBRARIES
    Publication number: 20190225960
    Abstract: Transposomes and oligonucleotide replacement methods to make DNA libraries that have distinct 5? and 3? tags, and to make directional libraries that are enriched for a desired strand.
    Type: Application
    Filed: April 1, 2019
    Publication date: July 25, 2019
    Inventors: IGOR GORYSHIN, BRADLEY BAAS, RAMESH VAIDYANATHAN, MARK MAFFITT
  • Oligonucleotide replacement for di-tagged and directional libraries
    Patent number: 10287574
    Abstract: Transposomes and oligonucleotide replacement methods to make DNA libraries that have distinct 5? and 3? tags, and to make directional libraries that are enriched for a desired strand.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: May 14, 2019
    Assignee: ILLUMINA, INC.
    Inventors: Igor Goryshin, Bradley Baas, Ramesh Vaidyanathan, Mark Maffitt
  • OLIGONUCLEOTIDE REPLACEMENT FOR DI-TAGGED AND DIRECTIONAL LIBRARIES
    Publication number: 20160090591
    Abstract: Transposomes and oligonucleotide replacement methods to make DNA libraries that have distinct 5? and 3? tags, and to make directional libraries that are enriched for a desired strand.
    Type: Application
    Filed: December 8, 2015
    Publication date: March 31, 2016
    Applicant: ILLUMINA, INC.
    Inventors: IGOR GORYSHIN, BRADLEY BAAS, RAMESH VAIDYANATHAN, MARK MAFFITT
  • Oligonucleotide replacement for di-tagged and directional libraries
    Patent number: 9238671
    Abstract: Transposomes and oligonucleotide replacement methods to make DNA libraries that have distinct 5? and 3? tags, and to make directional libraries that are enriched for a desired strand.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: January 19, 2016
    Assignee: ILLUMINA, INC.
    Inventors: Igor Goryshin, Bradley Baas, Ramesh Vaidyanathan, Mark Maffitt
  • OLIGONUCLEOTIDE REPLACEMENT FOR DI-TAGGED AND DIRECTIONAL LIBRARIES
    Publication number: 20140031261
    Abstract: Transposomes and oligonucleotide replacement methods to make DNA libraries that have distinct 5? and 3? tags, and to make directional libraries that are enriched for a desired strand.
    Type: Application
    Filed: January 30, 2012
    Publication date: January 30, 2014
    Applicant: Illumina, Inc
    Inventors: Igor Y. Goryshin, Bradley Baas, Ramesh Vaidyanathan, Mark Maffitt
  • Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same
    Patent number: 6998260
    Abstract: Disclosed is a method of expressing enzymatically-active, recombinant proteolytic tryptase in a eukaryotic host cell, expression constructs which drive the production of enzymatically-active tryptase in transformed hosts, and genetically-engineered eukaryotic host cells containing the expression constructs and which express enzymatically-active proteolytic tryptases. Uses for the proteolytic tryptases so produced are also disclosed. Also disclosed is a method of making active site mutants of proteolytic tryptases in a eukaryotic host cell, expression constructs which drive the production of the mutants in transformed eukaryotic host cells, and genetically-engineered eukaryotic host cells containing the expression constructs and which express the active-site mutated form of proteolytic tryptases.
    Type: Grant
    Filed: June 21, 2000
    Date of Patent: February 14, 2006
    Assignee: Promega Corporation
    Inventors: Mark Maffitt, Andrew L. Niles, Mary Haak-Frendscho